Tandem Blog
-
FDA's new ACE pump classification for the t:slim X2 insulin pump
On February 14, 2019, we announced that the t:slim X2™ insulin pump is the first to receive approval in a new device category called alternate controller enabled infusion (ACE) pumps. Here we break down what this REALLY means for our customers and the wider diabetes community.
Read Article -
The t:slim X2 insulin pump around the world
We’re grateful to our distribution partners around the world helping us bring the t:slim X2™ insulin pump to you!
Read Article -
Peace of Mind While Snowboarding with Basal-IQ Technology
After years away from the slopes, Matt Vande Vegte returned. This time with an insulin pump!
Read Article -
Leigh Vosseller, Chief Financial Officer and Executive Vice President
Leigh Vosseller, chief financial officer and executive vice president at Tandem Diabetes Care, was recognized in the Medical Design & Outsourcing November 2018 Special Edition: Women in Medtech! It’s about time we featured this important person behind our pump. We caught up with her about her work.
Read Article -
Basal-IQ® Technology: Trying It out for Myself
t:slim X2™ insulin pump user Ben Tzeel walks through his first ten days using Basal-IQ® technology and shares his main takeaways.
Read Article -
Day-by-day reports through the t:connect Diabetes Management Application
We are excited to announce the highly anticipated day-by-day Therapy Timeline printed report, now available through the t:connect® Diabetes Management Application.
Read Article
From time to time, we may pass along suggestions, tips, or information about other Tandem Diabetes Care insulin pump user experiences or approaches to the management of diabetes. Please note individual symptoms, situations, circumstances, and results may vary. Please consult your physician or qualified healthcare provider regarding your condition and appropriate medical treatment. Please read the Important Safety Information before using our products.